Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma?

Annals of Oncology

Volumn 24, Issue 3, 2013, Pages 832-837

  Le Pechoux C ^a   Musat, E ^a,b   Baey, C ^a   Al Mokhles, H ^a   Terrier, P ^a   Domont, J ^a   Le Cesne, A ^a   Laplanche, A ^a   Bonvalot, S ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

Author keywords

Adjuvant conformal radiotherapy; Combined modality; Enlarged surgery; Front line aggressive surgery; Retroperitoneal sarcoma

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FEMALE; FRONT LINE AGGRESSIVE SURGERY; HUMAN; MALE; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROPERITONEAL SARCOMA; RISK REDUCTION; TREATMENT FAILURE;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SARCOMA; YOUNG ADULT;

EID: 84874579231     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds516     Document Type: Article

References (32)

1. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 2006; 106: 1610-1616.
2. Stoeckle E, Coindre JM, Bonvalot S et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92: 359-368.
3. Lewis JJ, Leung D, Woodruff JM. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228: 355-365.
4. Hassan I, Park SZ, Donohue JH et al.. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg 2004; 239: 244-250.
5. van Dalen T, Plooij JM, van Coevorden F et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol 2007; 33: 234-238.
6. Bonvalot S, Cavalcanti A, Le Péchoux C et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol 2005; 31: 917-923.
7. Casali PG, Blay JY; ESMO/CONTICANET/EUROBONET Consensus Panel of Experts. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v198-v203.
8. Bonvalot S, Raut CP, Pollock RE et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 2012; 19: 2981-2991.
9. Bonvalot S, Rivoire M, Castaing M et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27: 31-37.
10. Gronchi A, Lo Vullo S, Fiore M et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 2009; 27: 24-30.
11. Trojani M, Contesso G, Coindre JM et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37-42.
12. UICC. Tumor of bone and soft tissues. R classification. In Sobin LH, Wittekind Ch (eds), TNM Classification of Malignant Tumours, 6th edition. New York: Wiley Liss 2002; 110.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
14. Sampath S, Hitchcock YJ, Shrieve DC et al. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol 2010; 101: 345-350.
15. Zhou Z, McDade TP, Simons JP et al. Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient. Arch Surg 2010; 145: 426-431.
16. Pawlik TM, Pisters PW, Mikula L et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediateor high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006; 13: 508-517.
17. Strauss DC, Hayes AJ, Thway K et al. Surgical management of primary retroperitoneal sarcoma. Br J Surg 2010; 101: 520-523.
18. Gronchi A, Miceli R, Colombo C et al. Frontline extended surgery is associated with improved survival in retroperitoneal low to intermediate-grade soft tissue sarcomas. Ann Oncol 2012; 23: 1067-1073.
19. Van De Voorde L, Delrue L, van Eijkeren M et al. Radiotherapy and surgery-an indispensable duo in the treatment of retroperitoneal sarcoma. Cancer 2011; 117: 4355-4364.
20. Bonvalot S, Miceli R, Berselli M. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol 2010; 17: 1507-1514.
21. Glenn J, Sindelar WF, Kinsella T et al. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery 1985; 97: 316-325.
22. Sindelar WF, Kinsella TJ, Chen PW et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 1993; 128: 402-410.
23. Letschert JG, Lebesque JV, Aleman BM et al. The volume effect in radiationrelated late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol 1994; 32: 116-123.
24. White JS, Biberdorf D, DiFrancesco LM et al. Use of tissue expanders and preoperative external beam radiotherapy in the treatment of retroperitoneal sarcoma. Ann Surg Oncol 2007; 14: 583-590.
25. Musat E, Kantor G, Caron J et al. Comparison of intensity-modulated postoperative radiotherapy with conventional postoperative conformal radiotherapy for retroperitoneal sarcoma. Cancer Radiother 2004; 8: 255-261.
26. Paumier A, Le Péchoux C, Beaudré A et al. IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?. Radiother Oncol 2011; 99: 73-78.
27. Tzeng CW, Fiveash JB, Popple RA et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer 2006; 107: 371-379.
28. Bossi A, De Wever I, Van Limbergen E et al. Intensity modulated radiationtherapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas. Int J Radiat Oncol Biol Phys 2007; 67: 164-170.
29. Choi AH, Barnholtz-Sloan JS, Kim JA. Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis. Ann Oncol 2012; 23: 2449-2457.
30. Gieschen HL, Spiro IJ, Suit HD et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2001; 50: 127-131.
31. Jones JJ, Catton CN, O'Sullivan B et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol 2002; 9: 346-354.
32. Pisters PW, Ballo MT, Fenstermacher MJ et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol 2003; 21: 3092-3097.